Publications by authors named "Ines Chevolet"

Claim this Profile
C
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma.
Lieve Brochez, Annabel Meireson, Inès Chevolet, Nora Sundahl, Piet Ost

Nat Commun· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile.
Annabel Meireson, Inès Chevolet, Eva Hulstaert, Liesbeth Ferdinande, Piet Ost

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma.
Lukas Krähenbühl, Simone M Goldinger, Joanna Mangana, Katrin Kerl, Ines Chevolet

Neoplasia· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy.
Lieve Brochez, Ines Chevolet, Vibeke Kruse

Eur J Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial.
Max Schreuer, Yanina Jansen, Simon Planken, Ines Chevolet, Teofila Seremet

Lancet Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.
Katrien De Wolf, Vibeke Kruse, Nora Sundahl, Mireille van Gele, Ines Chevolet

J Transl Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanoma.
Max Schreuer, Geert Meersseman, Sari van Den Herrewegen, Yanina Jansen, Teofila Seremet, Ines Chevolet

Melanoma Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Max Schreuer, Geert Meersseman, Sari Van Den Herrewegen, Yanina Jansen, Ines Chevolet

J Transl Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ex Vivo and In Vivo Dermoscopy in Dermatopathologic Evaluation of Skin Tumors.
Marc Haspeslagh, Katrien Vossaert, Sven Lanssens, Michael Noë, Isabelle Hoorens, Ines Chevolet

JAMA Dermatol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total-Body Examination vs Lesion-Directed Skin Cancer Screening.
Isabelle Hoorens, Katrien Vossaert, Lore Pil, Barbara Boone, Sofie De Schepper, Ines Chevolet

JAMA Dermatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?
Ines Chevolet, Max Schreuer, Reinhart Speeckaert, Bart Neyns, Isabelle Hoorens

Melanoma Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A short dermoscopy training increases diagnostic performance in both inexperienced and experienced dermatologists.
Ines Chevolet, Isabelle Hoorens, Astrid Janssens, Reinhart Speeckaert, Nanja Van Geel

Australas J Dermatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective responses can be obtained by CTLA-4 inhibition in metastatic melanoma after BRAF inhibitor failure.
Max S Schreuer, Ines L Chevolet, Yanina J Jansen, Teofila C Seremet, Sofie Wilgenhof

Melanoma Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.
Ines Chevolet, Reinhart Speeckaert, Max Schreuer, Bart Neyns, Olga Krysko

J Transl Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Peter Dynoodt, Reinhart Speeckaert, Olivier De Wever, Inès Chevolet, Lieve Brochez

Int J Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomelanoses in children.
Nanja van Geel, Marijn Speeckaert, Ines Chevolet, Sofie De Schepper, Hilde Lapeere

J Cutan Aesthet Surg· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma.
Reinhart Speeckaert, Nanja Van Geel, Jo Lambert, Barbara Boone, Ines Chevolet

Oncoimmunology· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis